Skip to main content
  • 236 Accesses

Abstract

Columbus brought tobacco from the New World. In the following centuries, the smoking of tobacco spread throughout the world, despite vigorous opposition. The tobacco plant was named Nicotiana tabacum after Jean Nicot, who promoted his belief that the plant had medicinal value.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Penn WA (1902). The Soverance Herbe: A History of Tobacco, p. 56. New York: Grant Richards.

    Google Scholar 

  2. Johnson LM (1942) Tobacco smoking and nicotine. Lancet2:742.

    Google Scholar 

  3. Warburton DW (1988). The puzzle of nicotine use. In The Psychopharmacology of Addiction, Chap. 3. New York: Oxford University Press.

    Google Scholar 

  4. Taylor P (1985). Ganglinic stimulating and blocking agents. In The Pharmacological Basis of Therapeutics, 7th Ed., Gilman AG, Goodman LA, Rail TW, Murad F, eds., Chap. 10. New York: Macmillan.

    Google Scholar 

  5. U.S. Department of Health & Human Services (1988). The Health Consequences of Smoking: Nicotine Addiction. A Report of the Surgeon General. Washington, DC: U.S. Gov. Printing Office.

    Google Scholar 

  6. Jarvik ME (1967). Tobacco smoking in monkeys. Ann NY Acad Sci142:280–294.

    Article  Google Scholar 

  7. U.S. Public Health Service (1986). The Consequences of Using Smokeless Tobacco. A Report of the Advisory Committee of the Surgeon General. DHEW Publications No. (PHS) 86–2874. Washington, DC: US. Gov. Printing Office.

    Google Scholar 

  8. Glover ED, Schroeder KL, Henningfield JE, et al. (1988). An interpretive review of smokeless tobacco research in the United States: Part I. J Drug Educ18 (4): 285.

    Article  PubMed  CAS  Google Scholar 

  9. National Institutes of Drug Abuse (1989). National High School Survey. National Institute of Drug Abuse. Washington, DC: US Gov. Printing Office.

    Google Scholar 

  10. Maxwell JC (1980). Maxwell manufactured products report: Chewing snuff is growth segment. Tob Rep107:32.

    Google Scholar 

  11. Siegal RK (1982). Cocaine smoking. J Psychoact Drugs14:272–341.

    Google Scholar 

  12. Gritz ER, Baer-Weiss V, Benowitz NL (1981). Plasma nicotine and cotinine concentration in habitual smokeless tobacco users. Clin Pharmacol Ther30:201.

    Article  PubMed  CAS  Google Scholar 

  13. Hoffman D, Hecht SS (1985). Nicotine-derived Af-nitrosamines and tobacco related cancer. Cancer Res45: 2285.

    Google Scholar 

  14. Wesnes K, Warburton DM (1983). Smoking, nicotine and human performance. Pharmacol Ther21:189–208.

    Article  PubMed  CAS  Google Scholar 

  15. Wise RA (1982). Neuroleptics and operant behavior: The anhedonia hypothesis. Behav Brain Sci5: 39–53.

    Article  Google Scholar 

  16. Henningfield JE (1984). Pharmacological basis and treatment of cigarette smoking. J Clin Psychiatry45: 24–34.

    PubMed  CAS  Google Scholar 

  17. Russell MAH (1971). Cigarette smoking: Natural history of a dependence disorder. Br J Med Psychol44:1–16.

    Article  PubMed  CAS  Google Scholar 

  18. Schuster CR, Thompson T (1969). Self-administration of and behavioral dependence on drugs. Ann Rev Pharmacol9:483–502.

    Article  PubMed  CAS  Google Scholar 

  19. Mello NK, Mendelson JH, Sellers ML, et al. (1980). Effects of heroin self-administration on cigarette smoking. Psychopharmacology67:45–52.

    Article  PubMed  CAS  Google Scholar 

  20. American Psychiatric Association (1987). Diagnostic and Statistical Manual of Mental Disorders, 3d Ed. (Revised). Washington, DC: American Psychiatric Association.

    Google Scholar 

  21. Pomerleau OF, Rosecrans J (1989). Neuroregulatory effects of nicotine. Psycho-neuroendocrinology14 (6): 407–423.

    Article  CAS  Google Scholar 

  22. Shiffman SM (1979). The tobacco withdrawal syndrome. In Cigarette Smoking as a Dependence Process, Krasnegor NA, ed. Washington, DC: National Institute for Drug Abuse.

    Google Scholar 

  23. Warburton DM (1987). The functions of smoking. In Tobacco Smoke and Nicotine: A Neurobiological Approach, p. 178–199. New York: Plenum Press.

    Google Scholar 

  24. Warburton DM (1975). Brain, Behaviour and Drugs. London: Wiley.

    Google Scholar 

  25. Jarvik ME, Henningfield JE (1988). Pharmacological treatment of tobacco dependence. Pharmacol Biochem Behav30:279.

    Article  PubMed  CAS  Google Scholar 

  26. Cocores JA, Sinaikin P, Gold MS (1989). Scopolamine as treatment for nicotine polacrilex dependence. Ann Clin Psychiatry (l):203–204.

    Google Scholar 

  27. Alcoholics Anonymous World Services, Inc. (1976). Alcoholics Anonymous, 3d Ed., p. 58. New York: Alcoholics Anonymous World Services.

    Google Scholar 

  28. Jeanne E (1984). The Twelve Steps for Smokers, p. 3. Center City, MN: Hazel-don Foundation.

    Google Scholar 

  29. Schneider N (1988). How to Use Nicotine Gum & Other Strategies to Quit Smoking. New York: Pocket Books.

    Google Scholar 

  30. Bobo JK (1989). Nicotine dependence and alcohol epidemiology and treatment. J Psychoact Drugs21 (3): 323.

    CAS  Google Scholar 

  31. Benowitz NL (1983). The use of biologic fluid samples in assessing tobacco smoke consumption. Natl Inst Drug Abuse Res Monogr Ser48:6.

    CAS  Google Scholar 

  32. Noland MP, Kryscio RJ, Riggs RS, et al. (1988). Saliva cotinine and thiocyanate: Chemical indicators of smokeless tobacco and cigarette use in adolescents. J Behav Med11 (5): 423.

    Article  PubMed  CAS  Google Scholar 

  33. Nanji AA, Lawrence AH (1988). Skin surface sampling for nicotine: A rapid, noninvasive method for identifying smokers. Int J Addict23 (11): 1207.

    PubMed  CAS  Google Scholar 

  34. Glassman AH, Jackson WK, Walsh BT, et al. (1984). Cigarette craving, smoking withdrawal, and Clonidine. Science226:864.

    Article  PubMed  CAS  Google Scholar 

  35. Glassman AH, Stetner MS, Walsh BT, et al. (1988). Heavy smokers, smoking cessation, and Clonidine. JAMA259 (19): 2863.

    Article  PubMed  CAS  Google Scholar 

  36. Bachynsky N (1986). The use of anticholinergic drugs for smoking cessation: A pilot study. Int J Addict789.

    Google Scholar 

  37. Sees KL, Stalcup SA (1989). Combining Clonidine and nicotine replacement for treatment of nicotine withdrawal. J Psychoact Drugs21 (3): 355.

    CAS  Google Scholar 

  38. Cocores JA, Gold MS (1989). Transdermal scopolamine for nicotine dependence: Use in non-addicts versus recovering addicts. In Proceedings of the American Society of Addiction Medicine, 20th Annual Conference, Atlanta, Georgia, p. 22.

    Google Scholar 

  39. Cocores JA, Gold MS (1991). Nicotine dependent psychiatric patients. In The Clinical Management of Nicotine Dependents, Cocores JA, ed., p. 420. New York: Springer-Verlag.

    Google Scholar 

  40. Cocores JA, Goias PR, Gold MS (1990). The medical management of nicotine dependence in the workplace. Ann Clin Psychiatry (l):237–240.

    Google Scholar 

  41. Cocores JA, Pottash AC (1991). Outpatient management of nicotine dependence. In The Clinical Management of Nicotine Dependence, Cocores JA, ed., p. 331. New York: Springer-Verlag.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 1991 Springer-Verlag New York

About this chapter

Cite this chapter

Miller, N.S. (1991). The Pharmacology of Nicotine. In: The Pharmacology of Alcohol and Drugs of Abuse and Addiction. Springer, New York, NY. https://doi.org/10.1007/978-1-4612-3044-1_19

Download citation

  • DOI: https://doi.org/10.1007/978-1-4612-3044-1_19

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4612-7774-3

  • Online ISBN: 978-1-4612-3044-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics